PDE4B Missense Variant Increases Susceptibility to Post-traumatic Stress Disorder-Relevant Phenotypes in Mice
Large-scale genome-wide association studies (GWASs) have associated intronic variants in <i>PDE4B</i>, encoding cAMP-specific phosphodiesterase-4B (PDE4B), with increased risk for post-traumatic stress disorder (PTSD), as well as schizophrenia and substance use disorders that are often comorbid with it. However, the pathophysiological mechanisms of genetic risk involving PDE4B are poorly understood. To examine the effects of PDE4B variation on phenotypes with translational relevance to psychiatric disorders, we focused on PDE4B missense variant M220T, which is present in the human genome as rare coding variant rs775201287. When expressed in HEK-293 cells, PDE4B1-M220T exhibited an attenuated response to a forskolin-elicited increase in the intracellular cAMP concentration. In behavioral tests, homozygous <i>Pde4b</i> <sup>M220T</sup> male mice with a C57BL/6JJcl background exhibited increased reactivity to novel environments, startle hyperreactivity, prepulse inhibition deficits, altered cued fear conditioning, and enhanced spatial memory, accompanied by an increase in cAMP signaling pathway-regulated expression of BDNF in the hippocampus. In response to a traumatic event (10 tone-shock pairings), neuronal activity was decreased in the cortex but enhanced in the amygdala and hippocampus of <i>Pde4b</i> <sup>M220T</sup> mice. At 24 h post-trauma, <i>Pde4b</i> <sup>M220T</sup> mice exhibited increased startle hyperreactivity and decreased plasma corticosterone levels, similar to phenotypes exhibited by PTSD patients. Trauma-exposed <i>Pde4b</i> <sup>M220T</sup> mice also exhibited a slower decay in freezing at 15 and 30 d post-trauma, demonstrating enhanced persistence of traumatic memories, similar to that exhibited by PTSD patients. These findings provide substantive mouse model evidence linking PDE4B variation to PTSD-relevant phenotypes and thus highlight how genetic variation of PDE4B may contribute to PTSD risk.
Authors
- Christina Elliott (ORCID: https://orcid.org/0000-0002-2838-8612)
- Jonathan G.L. Mullins (ORCID: https://orcid.org/0000-0003-0144-2962)
- Shupeng Li (ORCID: https://orcid.org/0000-0002-7807-374X)
- George S. Baillie (ORCID: https://orcid.org/0000-0003-2469-6316)
- Steven J. Clapcote (ORCID: https://orcid.org/0000-0002-6662-5690)
- Tatiana V. Lipina (ORCID: https://orcid.org/0000-0003-1823-465X)
- James R. Woodgett (ORCID: https://orcid.org/0000-0003-3731-5797)
- Alexander McGirr (ORCID: https://orcid.org/0000-0002-8425-3958)
- Yoichi Gondo (ORCID: https://orcid.org/0000-0003-2184-6489)
- Tamara G. Amstislavskaya (ORCID: https://orcid.org/0000-0002-2656-8687)
- Е. С. Петрова (ORCID: https://orcid.org/0000-0002-7640-4867)
- Ryan T. Cameron
Institutions
- Mount Sinai Hospital (CA)
- University of Leeds (GB)
- University of Calgary (CA)
- Shenzhen University (CN)
- University of Toronto (CA)
- Peking University (CN)
- Lunenfeld-Tanenbaum Research Institute (CA)
- Swansea University (GB)
- Institute of Physiology and Basic Medicine (RU)
- RIKEN BioResource Research Center (JP)
- Peking University Shenzhen Hospital (CN)
- Hotchkiss Brain Institute (CA)
- University of Glasgow (GB)
Publication Details
- Journal
- Journal of Neuroscience
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1523/jneurosci.0137-24.2024
- Citations
- 6
- Primary Topic
- Phosphodiesterase function and regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- University of Leeds
- Medical Research Council
- Biotechnology and Biological Sciences Research Council